Cargando…
Artificial Macrocycles as Potent p53–MDM2 Inhibitors
[Image: see text] Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53–MDM2 interaction was designed and synthesized. These macrocycles, alternatively to stapled peptides, target for the first time the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641952/ https://www.ncbi.nlm.nih.gov/pubmed/29057045 http://dx.doi.org/10.1021/acsmedchemlett.7b00219 |
_version_ | 1783271292180365312 |
---|---|
author | Estrada-Ortiz, Natalia Neochoritis, Constantinos G. Twarda-Clapa, Aleksandra Musielak, Bogdan Holak, Tad A. Dömling, Alexander |
author_facet | Estrada-Ortiz, Natalia Neochoritis, Constantinos G. Twarda-Clapa, Aleksandra Musielak, Bogdan Holak, Tad A. Dömling, Alexander |
author_sort | Estrada-Ortiz, Natalia |
collection | PubMed |
description | [Image: see text] Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53–MDM2 interaction was designed and synthesized. These macrocycles, alternatively to stapled peptides, target for the first time the large hydrophobic surface area formed by Tyr67, Gln72, His73, Val93, and Lys94 yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using fluorescence polarization (FP) assay and (1)H–(15)N two-dimensional HSQC nuclear magnetic resonance experiments. |
format | Online Article Text |
id | pubmed-5641952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-56419522017-10-22 Artificial Macrocycles as Potent p53–MDM2 Inhibitors Estrada-Ortiz, Natalia Neochoritis, Constantinos G. Twarda-Clapa, Aleksandra Musielak, Bogdan Holak, Tad A. Dömling, Alexander ACS Med Chem Lett [Image: see text] Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53–MDM2 interaction was designed and synthesized. These macrocycles, alternatively to stapled peptides, target for the first time the large hydrophobic surface area formed by Tyr67, Gln72, His73, Val93, and Lys94 yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using fluorescence polarization (FP) assay and (1)H–(15)N two-dimensional HSQC nuclear magnetic resonance experiments. American Chemical Society 2017-09-20 /pmc/articles/PMC5641952/ /pubmed/29057045 http://dx.doi.org/10.1021/acsmedchemlett.7b00219 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | Estrada-Ortiz, Natalia Neochoritis, Constantinos G. Twarda-Clapa, Aleksandra Musielak, Bogdan Holak, Tad A. Dömling, Alexander Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title | Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title_full | Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title_fullStr | Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title_full_unstemmed | Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title_short | Artificial Macrocycles as Potent p53–MDM2 Inhibitors |
title_sort | artificial macrocycles as potent p53–mdm2 inhibitors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641952/ https://www.ncbi.nlm.nih.gov/pubmed/29057045 http://dx.doi.org/10.1021/acsmedchemlett.7b00219 |
work_keys_str_mv | AT estradaortiznatalia artificialmacrocyclesaspotentp53mdm2inhibitors AT neochoritisconstantinosg artificialmacrocyclesaspotentp53mdm2inhibitors AT twardaclapaaleksandra artificialmacrocyclesaspotentp53mdm2inhibitors AT musielakbogdan artificialmacrocyclesaspotentp53mdm2inhibitors AT holaktada artificialmacrocyclesaspotentp53mdm2inhibitors AT domlingalexander artificialmacrocyclesaspotentp53mdm2inhibitors |